世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医薬品用アミノ酸の世界市場レポート、歴史と予測 2017-2028年


Global Pharmaceutical Amino Acids Market Report, History and Forecast 2017-2028

市場の分析と洞察。医薬品用アミノ酸の世界市場 医薬品用アミノ酸の世界市場は、2021年に13億2613万米ドルと評価され、2028年末には15億6919万米ドルに達し、2022年から2028年の間に2.5%の年平均成長率で成長す... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年10月24日 US$3,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場の分析と洞察。医薬品用アミノ酸の世界市場
医薬品用アミノ酸の世界市場は、2021年に13億2613万米ドルと評価され、2028年末には15億6919万米ドルに達し、2022年から2028年の間に2.5%の年平均成長率で成長すると予測されています。

業界では、世界の医薬品アミノ酸市場の主要なプレーヤーは、味の素、エボニック、協和発酵、AMINO、Meihua Holding Group、Tianjin Tianyao、Jingjing、Wuxi Jinghai、Jiahe Biotech、Hubei Bafeng、グランドホヨ、Yichang Sanxia ProudinおよびShine Starなどのようなものです。2021年と近年は味の素の出荷量が最も多く、エボニックと協和発酵が2位と3位を占めており、戦略の違いから市場シェアの差は拡大し続けている。過去3年間の市場集中度を見ると、上位5社で67.44%を占めている。2021年の医薬品アミノ酸の売上高では、上位5社が市場の67.44%を占めている。
アジアは世界最大の輸出量とメーカーを有し、世界の主要企業はすべて中国に生産拠点を置いています。

医薬品用アミノ酸市場は、世界的に需要が拡大しており、今後も着実な成長が予測されます。特にバイオ医薬品を中心とした高品質なアミノ酸の需要が伸びています。また、抗体医薬やバイオシミラー(生物学的製剤の後続品)の開発が進んでいることから、バイオ医薬品用培地市場も引き続き高い成長が期待されています。ただし、ウクライナ情勢に起因する物流遅延や原燃料価格の高騰などの要因に注視していく必要があります。
医薬品用アミノ酸市場は、アミノ酸の種類により、グリシン、L-スレオニン、L-アラニン、L-ロイシン、L-システイン、L-アルギニン、L-バリン、L-イソロイシン、その他に分類されます。グリシンが最も多いタイプで、2021年の販売量は16,650トンとなり、全体の約31.68%を占めている。医薬品用アミノ酸のL-アラニンおよびL-イソロイシンセグメントは、予測期間中に最も高いCAGRを記録すると予測されます。

医薬品用アミノ酸の最大の用途は、医薬品原薬(API)であると推定されます。細胞培養液原料は、今後数年間、医薬品アミノ酸市場で最も速い成長率を示すと予測されています。
COVID-19の影響により、小規模メーカーの稼働率が低下し、大手メーカーのシェアが急速に高まっています。今後5年間は大手メーカーの生産能力拡大が続くと予想される。

2022年の市場成長率(数量ベース)は6.99%を超えると予想される。
医薬品用アミノ酸市場は地域別に、アジア、欧州、USMCA、中東、CIS、中南米、アフリカ、オセアニアに区分されています。USMCAは、予測期間中に最大の市場になると予測されています。中国やインドなどの発展途上国では、医薬品用アミノ酸の需要が高いです。高い成長とイノベーション、そして業界の統合が、この地域の市場を牽引すると予想されます。
生産面では、2017年から2022年まで、そして2028年までの予測として、医薬品アミノ酸の生産能力、生産量、成長率、メーカー別、地域レベル、国レベルの市場シェアを調査しています。
なお、本レポートにおける生産能力は主に銘板容量であり、メーカーの生産能力データには合弁会社の分も含まれています。

本レポートに記載されている収益市場規模は、医薬品アミノ酸の市場価格に従って計算された生産額を指していることに留意してください。製薬用アミノ酸の生産企業の多くは、川下の派生品製造事業を有しており、企業間で取引される製薬用アミノ酸は、通常、市場価格に加工費を加えた価格で提示される。
本レポートでは、MTはMetric Tones(メートル トーン)を指す。
販売面では、地域(国)別、企業別、進捗別、用途別の医薬品アミノ酸の販売に焦点を当て、2017年から2022年まで、2028年までの予測を掲載しています。

世界の医薬品アミノ酸市場は、市場力学、市場競争、地域成長、セグメント別分析、主要成長戦略に大きな焦点を当て、レポート内で徹底的に、正確に、包括的に評価されています。本レポートの購入者は、収益および数量ベースの世界市場規模など、検証済みの市場数値にアクセスすることができます。生産分析の一環として、本レポートの著者は、世界の医薬品用アミノ酸市場の進歩セグメント別の世界収益と数量について信頼性の高い推定と計算を提供しています。これらの数値は、2017-2028年の期間において、収益と数量の両方で提供されています。さらに、同期間における地域別の生産量についても、収益と数量の両面から正確な数字を提供しています。また、同期間の生産能力統計も掲載しています。

企業別
味の素
エボニック
協和発酵
アミノ
美華控股集団
天津天洋
ジンジン
無錫精海
嘉和バイオテック
湖北八峰
グランドホヨ
宜昌三夏プロイディン
シャインスター

種類別セグメント
グリシン
L-スレオニン
L-アラニン
L-ロイシン
L-システイン
L-アルギニン
L-バリン
L-イソロイシン
その他

用途別セグメント
医薬品原体(API)
医薬品中間体
細胞培養基材
医薬品添加物
医療用食品
その他

地域別売上高
アジア太平洋地域
欧州
USMCA
中近東・アフリカ
CIS
中央・南アメリカ
中国
日本
韓国
インド
台湾 中国
インドネシア
タイ
ドイツ
フランス
イタリア
イギリス
オランダ
スペイン
スイス
米国
メキシコ
カナダ
サウジアラビア
イラン
ブラジル
アルゼンチン




ページTOPに戻る


目次

1 Pharmaceutical Amino Acids Market Overview 1
1.1 Pharmaceutical Amino Acids Product Overview 1
1.2 Pharmaceutical Amino Acids Market Segment By Type 6
1.2.1 Glycine 6
1.2.2 L-Threonine 7
1.2.3 L-Alanine 8
1.2.4 L-Leucine 9
1.2.5 L-Cysteine 10
1.2.6 L-Arginine 11
1.2.7 L-Valine 12
1.2.8 L-Isoleucine 13
1.2.9 Others 14
1.3 Global Pharmaceutical Amino Acids Market Size By Type 14
1.3.1 Global Pharmaceutical Amino Acids Market Size Overview By Type (2017-2028) 15
1.3.2 Global Pharmaceutical Amino Acids Historic Market Size Review By Type (2017-2022) 16
1.3.3 Global Pharmaceutical Amino Acids Forecasted Market Size By Type (2023-2028) 19
1.4 Key Regions Market Size Segment By Type 22
1.4.1 Usmca Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 22
1.4.2 Europe Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 23
1.4.3 Asia Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 24
1.4.4 Middle East Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 25
1.4.5 Central & South America Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 26
1.4.6 Cis Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 27
1.4.7 Africa Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 29
1.4.8 Oceania Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 30
2 Pharmaceutical Amino Acids Market Competition By Company 32
2.1 Global Top Players By Pharmaceutical Amino Acids Sales (2017-2022) 32
2.2 Global Top Players By Pharmaceutical Amino Acids Revenue (2017-2022) 33
2.3 Global Top Players By Pharmaceutical Amino Acids Price (2017-2022) 34
2.4 Global Top Manufacturers Pharmaceutical Amino Acids Manufacturing Base 35
2.5 Pharmaceutical Amino Acids Market Competitive Situation And Trends 36
2.5.1 Pharmaceutical Amino Acids Market Concentration Rate (2017-2022) 36
2.5.2 Global 5 And 10 Largest Manufacturers By Pharmaceutical Amino Acids Sales And Revenue In 2021 37
2.6 Global Top Manufacturers By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Pharmaceutical Amino Acids As Of 2021) 37
3 Pharmaceutical Amino Acids Status And Outlook By Region 39
3.1 Global Pharmaceutical Amino Acids Market Size And Cagr By Region: 2017 Vs 2021 Vs 2028 39
3.2 Global Pharmaceutical Amino Acids Historic Market Size By Region 40
3.2.1 Global Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 40
3.2.2 Global Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 41
3.2.3 Global Pharmaceutical Amino Acids Sales (Volume & Value), Price And Gross Margin (2017-2022) 42
3.3 Global Pharmaceutical Amino Acids Forecasted Market Size By Region 42
3.3.1 Global Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 42
3.3.2 Global Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 43
3.3.3 Global Pharmaceutical Amino Acids Sales (Volume & Value), Price And Gross Margin (2023-2028) 43
4 Pharmaceutical Amino Acids By Application 45
4.1 Pharmaceutical Amino Acids Market Segment By Application 45
4.1.1 Active Pharmaceuticals Ingredients (Apis) 45
4.1.2 Pharmaceutical Intermediates 46
4.1.3 Cell Culture Media Ingredients 46
4.1.4 Pharmaceutical Excipients 47
4.1.5 Medical Food 48
4.1.6 Others 49
4.2 Global Pharmaceutical Amino Acids Market Size By Application 49
4.2.1 Global Pharmaceutical Amino Acids Market Size Overview By Application (2017-2028) 50
4.2.2 Global Pharmaceutical Amino Acids Historic Market Size Review By Application (2017-2022) 51
4.2.3 Global Pharmaceutical Amino Acids Forecasted Market Size By Application (2023-2028) 54
4.3 Key Regions Market Size Segment By Application 56
4.3.1 Usmca Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 56
4.3.2 Europe Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 57
4.3.3 Asia Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 58
4.3.4 Middle East Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 59
4.3.5 Central & South America Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 60
4.3.6 Cis Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 61
4.3.7 Africa Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 62
4.3.8 Oceania Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 63
5 Usmca Pharmaceutical Amino Acids By Region 65
5.1 Usmca Pharmaceutical Amino Acids Historic Market Size By Region 65
5.1.1 Usmca Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 65
5.1.2 Usmca Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 65
5.2 Usmca Pharmaceutical Amino Acids Forecasted Market Size By Region 66
5.2.1 Usmca Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 66
5.2.2 Usmca Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 66
6 Asia Pharmaceutical Amino Acids By Region 67
6.1 Asia Pharmaceutical Amino Acids Historic Market Size By Region 67
6.1.1 Asia Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 67
6.1.2 Asia Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 67
6.2 Asia Pharmaceutical Amino Acids Forecasted Market Size By Region 68
6.2.1 Asia Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 68
6.2.2 Asia Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 69
7 Europe Pharmaceutical Amino Acids By Country 70
7.1 Europe Pharmaceutical Amino Acids Historic Market Size By Country 70
7.1.1 Europe Pharmaceutical Amino Acids Sales In Volume By Country (2017-2022) 70
7.1.2 Europe Pharmaceutical Amino Acids Sales In Value By Country (2017-2022) 70
7.2 Europe Pharmaceutical Amino Acids Forecasted Market Size By Country 71
7.2.1 Europe Pharmaceutical Amino Acids Sales In Volume By Country (2023-2028) 71
7.2.2 Europe Pharmaceutical Amino Acids Sales In Value By Country (2023-2028) 72
8 Middle East Pharmaceutical Amino Acids By Region 73
8.1 Middle East Pharmaceutical Amino Acids Historic Market Size By Region 73
8.1.1 Middle East Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 73
8.1.2 Middle East Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 73
8.2 Middle East Pharmaceutical Amino Acids Forecasted Market Size By Region 74
8.2.1 Middle East Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 74
8.2.2 Middle East Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 74
9 Central & South America Pharmaceutical Amino Acids By Region 75
9.1 Central & South America Pharmaceutical Amino Acids Historic Market Size By Region 75
9.1.1 Central & South America Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 75
9.1.2 Central & South America Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 75
9.2 Central & South America Pharmaceutical Amino Acids Forecasted Market Size By Region 76
9.2.1 Central & South America Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 76
9.2.2 Central & South America Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 76
10 Company Profiles And Key Figures In Pharmaceutical Amino Acids Business 78
10.1 Ajinomoto (Japan) 78
10.1.1 Ajinomoto Corporation Information 78
10.1.2 Ajinomoto Introduction And Business Overview 79
10.1.3 Ajinomoto Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 80
10.1.4 Ajinomoto Pharmaceutical Amino Acids Products Offered 81
10.1.5 Ajinomoto Recent Development 91
10.2 Evonik (Germany) 92
10.2.1 Evonik Corporation Information 92
10.2.2 Evonik Introduction And Business Overview 93
10.2.3 Evonik Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 95
10.2.4 Evonik Pharmaceutical Amino Acids Products Offered 95
10.2.5 Evonik Recent Development 97
10.3 Kyowa Hakko (Japan) 98
10.3.1 Kyowa Hakko Corporation Information 98
10.3.2 Kyowa Hakko Introduction And Business Overview 99
10.3.3 Kyowa Hakko Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 100
10.3.4 Kyowa Hakko Pharmaceutical Amino Acids Products Offered 100
10.3.5 Kyowa Hakko Recent Development 105
10.4 Amino (Germany) 106
10.4.1 Amino Corporation Information 106
10.4.2 Amino Introduction And Business Overview 107
10.4.3 Amino Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 108
10.4.4 Amino Pharmaceutical Amino Acids Products Offered 108
10.4.5 Amino Recent Development 109
10.5 Meihua Holdings Group (China) 110
10.5.1 Meihua Holdings Group Corporation Information 110
10.5.2 Meihua Holdings Group Introduction And Business Overview 111
10.5.3 Meihua Holdings Group Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 112
10.5.4 Meihua Holdings Group Pharmaceutical Amino Acids Products Offered 112
10.5.5 Meihua Holdings Group Recent Development 113
10.6 Tianjin Tianyao (China) 114
10.6.1 Tianjin Tianyao Corporation Information 114
10.6.2 Tianjin Tianyao Introduction And Business Overview 114
10.6.3 Tianjin Tianyao Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 115
10.6.4 Tianjin Tianyao Pharmaceutical Amino Acids Products Offered 115
10.7 Jingjing (China) 116
10.7.1 Jingjing Corporation Information 116
10.7.2 Jingjing Introduction And Business Overview 116
10.7.3 Jingjing Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 117
10.7.4 Jingjing Pharmaceutical Amino Acids Products Offered 118
10.8 Wuxi Jinghai (China) 118
10.8.1 Wuxi Jinghai Corporation Information 118
10.8.2 Wuxi Jinghai Introduction And Business Overview 119
10.8.3 Wuxi Jinghai Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 119
10.8.4 Wuxi Jinghai Pharmaceutical Amino Acids Products Offered 120
10.9 Jiahe Biotech (China) 121
10.9.1 Jiahe Biotech Corporation Information 121
10.9.2 Jiahe Biotech Introduction And Business Overview 121
10.9.3 Jiahe Biotech Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 122
10.9.4 Jiahe Biotech Pharmaceutical Amino Acids Products Offered 122
10.10 Hubei Bafeng (China) 125
10.10.1 Hubei Bafeng Corporation Information 125
10.10.2 Hubei Bafeng Introduction And Business Overview 126
10.10.3 Hubei Bafeng Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 126
10.10.4 Hubei Bafeng Pharmaceutical Amino Acids Products Offered 127
10.10.5 Hubei Bafeng Recent Development 127
10.11 Grand Hoyo (China) 128
10.11.1 Grand Hoyo Corporation Information 128
10.11.2 Grand Hoyo Introduction And Business Overview 129
10.11.3 Grand Hoyo Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 129
10.11.4 Grand Hoyo Pharmaceutical Amino Acids Products Offered 130
10.11.5 Grand Hoyo Recent Development 133
10.12 Yichang Sanxia Proudin (China) 133
10.12.1 Yichang Sanxia Proudin Corporation Information 133
10.12.2 Yichang Sanxia Proudin Introduction And Business Overview 134
10.12.3 Yichang Sanxia Proudin Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 135
10.12.4 Yichang Sanxia Proudin Pharmaceutical Amino Acids Products Offered 135
10.12.5 Yichang Sanxia Proudin Recent Development 137
10.13 Shine Star (China) 138
10.13.1 Shine Star Corporation Information 138
10.13.2 Shine Star Introduction And Business Overview 139
10.13.3 Shine Star Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 140
10.13.4 Shine Star Pharmaceutical Amino Acids Products Offered 141
11 Upstream, Opportunities, Challenges, Risks And Influences Factors Analysis 142
11.1 Pharmaceutical Amino Acids Key Raw Materials 142
11.1.1 Key Raw Materials 142
11.1.2 Key Raw Materials Price 144
11.1.3 Raw Materials Key Suppliers 144
11.2 Manufacturing Cost Structure 145
11.3 Pharmaceutical Amino Acids Industrial Chain Analysis 145
11.4 Pharmaceutical Amino Acids Market Dynamics 146
11.4.1 Industry Trends 146
11.4.2 Market Drivers 146
11.4.3 Market Challenges 147
11.4.4 Market Restraints 147
12 Marketing Strategy Analysis, Distributors 149
12.1 Sales Channel 149
12.2 Pharmaceutical Amino Acids Distributors 150
12.3 Pharmaceutical Amino Acids Downstream Customers 151
13 Research Findings And Conclusion 152
14 Appendix 154
14.1 Methodology/Research Approach 154
14.1.1 Research Programs/Design 154
14.1.2 Market Size Estimation 154
14.1.3 Market Breakdown And Data Triangulation 156
14.2 Data Source 156
14.2.1 Secondary Sources 156
14.2.2 Primary Sources 157
14.3 Disclaimer 158
14.4 Author List 158

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Pharmaceutical Amino Acids Market
The global Pharmaceutical Amino Acids market was valued at US$ 1,326.13 million in 2021 and will reach US$ 1,569.19 million by the end of 2028, growing at a CAGR of 2.5% during 2022-2028.

In the industry, the key players in the global Pharmaceutical Amino Acids market are like Ajinomoto, Evonik, Kyowa Hakko, AMINO, Meihua Holding Group, Tianjin Tianyao, Jingjing, Wuxi Jinghai, Jiahe Biotech, Hubei Bafeng, Grand Hoyo, Yichang Sanxia Proudin and Shine Star, etc. Ajinomoto shipments most in 2021 and recent years, while Evonik and Kyowa Hakko ranked 2 and 3.The gap of market share is keep on enlarged due to different strategy. The market concentration ratio in the past three years. The top five manufacturers held 67.44% of the market, in terms of Pharmaceutical Amino Acids revenue in 2021.
Asia has the largest global export quantity and manufacturers in Pharmaceutical Amino Acids market, global leading companies all have production bases in China.

Demand is growing worldwide in the market for amino acids for pharmaceuticals, and steady growth is forecast to continue. The demand for high-quality amino acids centering on the biopharmaceuticals business in particular is growing. Also, since development is proceeding on antibody drugs and biosimilars (follow-on biologics), strong growth is expected to continue in the culture media market for biopharmaceuticals. However, we must keep a close watch on factors such as distribution delays and the skyrocketing costs of raw materials and fuel stemming from the Ukraine situation.
On the basis of amino acids type, the Pharmaceutical Amino Acids market has been segmented into Glycine, L-Threonine, L-Alanine, L-Leucine, L-Cysteine, L-Arginine, L-Valine, L-Isoleucine and Others. Glycine is the largest type, Glycine accounts for about 31.68% of the total sales in 2021, with a sales volume of 16,650 metric tons. The L-Alanine and L-Isoleucine segment of Pharmaceutical Amino Acids is projected to register the highest CAGR during the forecast period.

Active Pharmaceuticals Ingredients (APIs) is estimated to be the largest application of Pharmaceutical Amino Acids. Cell Culture Media Ingredients are expected to show the fastest growth rates in the Pharmaceutical Amino Acids market in the coming years.
Affected by the COVID-19, the operating rate of small manufacturer has declined, and the market share of large manufacturer has increased rapidly. It is expected that major manufacturer will continue to expand production capacity in the next five years.

The market growth rate (by volume) is expected to exceed 6.99% in 2022.
On the basis of region, the Pharmaceutical Amino Acids market has been segmented into Asia, Europe, USMCA, Middle East, CIS, Central & South America, Africa, Oceania. USMCA is projected to be the largest market during the forecast period. The demand for Pharmaceutical Amino Acids is high in developing economies such as China and India. High growth and innovation, along with industry consolidations, are expected to drive the market in the region.
In terms of production side, this report researches the Pharmaceutical Amino Acids capacity, production, growth rate, market share by manufacturers and regional level and country level, from 2017 to 2022, and forecast to 2028.
The production capacity in this report is mainly based on the nameplate capacity, and the manufacturer's capacity data includes the part of the joint venture.

It should be pointed out that the revenue market size described in this report refers to the output value calculated according to the market price of Pharmaceutical Amino Acids. Most Pharmaceutical Amino Acids production enterprises have downstream derivatives manufacturing business, and the Pharmaceutical Amino Acids traded between enterprises are usually quoted based on the market price, plus processing fees.
In this report, MT refers to Metric Tones.
In terms of sales side, this report focuses on the sales of Pharmaceutical Amino Acids by regions (countries), company, by Progress and by Application. from 2017 to 2022 and forecast to 2028.

The global Pharmaceutical Amino Acids market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Progress segment of the global Pharmaceutical Amino Acids market. These figures have been provided in terms of both revenue and volume for the period 2017-2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

By Company
Ajinomoto
Evonik
Kyowa Hakko
AMINO
Meihua Holding Group
Tianjin Tianyao
Jingjing
Wuxi Jinghai
Jiahe Biotech
Hubei Bafeng
Grand Hoyo
Yichang Sanxia Proudin
Shine Star

Segment by Type
Glycine
L-Threonine
L-Alanine
L-Leucine
L-Cysteine
L-Arginine
L-Valine
L-Isoleucine
Others

Segment by Application
Active Pharmaceuticals Ingredients (APIs)
Pharmaceutical Intermediates
Cell Culture Media Ingredients
Pharmaceutical Excipients
Medical Food
Others

Sales by Region
Asia Pacific
Europe
USMCA
Middle East and Africa
CIS
Central & South America
China
Japan
South Korea
India
Taiwan China
Indonesia
Thailand
Germany
France
Italy
United Kingdom
Netherlands
Spain
Switzerland
United States
Mexico
Canada
Saudi Arabia
Iran
Brazil
Argentina




ページTOPに戻る


Table of Contents

1 Pharmaceutical Amino Acids Market Overview 1
1.1 Pharmaceutical Amino Acids Product Overview 1
1.2 Pharmaceutical Amino Acids Market Segment By Type 6
1.2.1 Glycine 6
1.2.2 L-Threonine 7
1.2.3 L-Alanine 8
1.2.4 L-Leucine 9
1.2.5 L-Cysteine 10
1.2.6 L-Arginine 11
1.2.7 L-Valine 12
1.2.8 L-Isoleucine 13
1.2.9 Others 14
1.3 Global Pharmaceutical Amino Acids Market Size By Type 14
1.3.1 Global Pharmaceutical Amino Acids Market Size Overview By Type (2017-2028) 15
1.3.2 Global Pharmaceutical Amino Acids Historic Market Size Review By Type (2017-2022) 16
1.3.3 Global Pharmaceutical Amino Acids Forecasted Market Size By Type (2023-2028) 19
1.4 Key Regions Market Size Segment By Type 22
1.4.1 Usmca Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 22
1.4.2 Europe Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 23
1.4.3 Asia Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 24
1.4.4 Middle East Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 25
1.4.5 Central & South America Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 26
1.4.6 Cis Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 27
1.4.7 Africa Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 29
1.4.8 Oceania Pharmaceutical Amino Acids Sales Breakdown By Type (2017-2022) 30
2 Pharmaceutical Amino Acids Market Competition By Company 32
2.1 Global Top Players By Pharmaceutical Amino Acids Sales (2017-2022) 32
2.2 Global Top Players By Pharmaceutical Amino Acids Revenue (2017-2022) 33
2.3 Global Top Players By Pharmaceutical Amino Acids Price (2017-2022) 34
2.4 Global Top Manufacturers Pharmaceutical Amino Acids Manufacturing Base 35
2.5 Pharmaceutical Amino Acids Market Competitive Situation And Trends 36
2.5.1 Pharmaceutical Amino Acids Market Concentration Rate (2017-2022) 36
2.5.2 Global 5 And 10 Largest Manufacturers By Pharmaceutical Amino Acids Sales And Revenue In 2021 37
2.6 Global Top Manufacturers By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Pharmaceutical Amino Acids As Of 2021) 37
3 Pharmaceutical Amino Acids Status And Outlook By Region 39
3.1 Global Pharmaceutical Amino Acids Market Size And Cagr By Region: 2017 Vs 2021 Vs 2028 39
3.2 Global Pharmaceutical Amino Acids Historic Market Size By Region 40
3.2.1 Global Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 40
3.2.2 Global Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 41
3.2.3 Global Pharmaceutical Amino Acids Sales (Volume & Value), Price And Gross Margin (2017-2022) 42
3.3 Global Pharmaceutical Amino Acids Forecasted Market Size By Region 42
3.3.1 Global Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 42
3.3.2 Global Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 43
3.3.3 Global Pharmaceutical Amino Acids Sales (Volume & Value), Price And Gross Margin (2023-2028) 43
4 Pharmaceutical Amino Acids By Application 45
4.1 Pharmaceutical Amino Acids Market Segment By Application 45
4.1.1 Active Pharmaceuticals Ingredients (Apis) 45
4.1.2 Pharmaceutical Intermediates 46
4.1.3 Cell Culture Media Ingredients 46
4.1.4 Pharmaceutical Excipients 47
4.1.5 Medical Food 48
4.1.6 Others 49
4.2 Global Pharmaceutical Amino Acids Market Size By Application 49
4.2.1 Global Pharmaceutical Amino Acids Market Size Overview By Application (2017-2028) 50
4.2.2 Global Pharmaceutical Amino Acids Historic Market Size Review By Application (2017-2022) 51
4.2.3 Global Pharmaceutical Amino Acids Forecasted Market Size By Application (2023-2028) 54
4.3 Key Regions Market Size Segment By Application 56
4.3.1 Usmca Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 56
4.3.2 Europe Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 57
4.3.3 Asia Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 58
4.3.4 Middle East Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 59
4.3.5 Central & South America Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 60
4.3.6 Cis Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 61
4.3.7 Africa Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 62
4.3.8 Oceania Pharmaceutical Amino Acids Sales Breakdown By Application (2017-2022) 63
5 Usmca Pharmaceutical Amino Acids By Region 65
5.1 Usmca Pharmaceutical Amino Acids Historic Market Size By Region 65
5.1.1 Usmca Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 65
5.1.2 Usmca Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 65
5.2 Usmca Pharmaceutical Amino Acids Forecasted Market Size By Region 66
5.2.1 Usmca Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 66
5.2.2 Usmca Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 66
6 Asia Pharmaceutical Amino Acids By Region 67
6.1 Asia Pharmaceutical Amino Acids Historic Market Size By Region 67
6.1.1 Asia Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 67
6.1.2 Asia Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 67
6.2 Asia Pharmaceutical Amino Acids Forecasted Market Size By Region 68
6.2.1 Asia Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 68
6.2.2 Asia Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 69
7 Europe Pharmaceutical Amino Acids By Country 70
7.1 Europe Pharmaceutical Amino Acids Historic Market Size By Country 70
7.1.1 Europe Pharmaceutical Amino Acids Sales In Volume By Country (2017-2022) 70
7.1.2 Europe Pharmaceutical Amino Acids Sales In Value By Country (2017-2022) 70
7.2 Europe Pharmaceutical Amino Acids Forecasted Market Size By Country 71
7.2.1 Europe Pharmaceutical Amino Acids Sales In Volume By Country (2023-2028) 71
7.2.2 Europe Pharmaceutical Amino Acids Sales In Value By Country (2023-2028) 72
8 Middle East Pharmaceutical Amino Acids By Region 73
8.1 Middle East Pharmaceutical Amino Acids Historic Market Size By Region 73
8.1.1 Middle East Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 73
8.1.2 Middle East Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 73
8.2 Middle East Pharmaceutical Amino Acids Forecasted Market Size By Region 74
8.2.1 Middle East Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 74
8.2.2 Middle East Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 74
9 Central & South America Pharmaceutical Amino Acids By Region 75
9.1 Central & South America Pharmaceutical Amino Acids Historic Market Size By Region 75
9.1.1 Central & South America Pharmaceutical Amino Acids Sales In Volume By Region (2017-2022) 75
9.1.2 Central & South America Pharmaceutical Amino Acids Sales In Value By Region (2017-2022) 75
9.2 Central & South America Pharmaceutical Amino Acids Forecasted Market Size By Region 76
9.2.1 Central & South America Pharmaceutical Amino Acids Sales In Volume By Region (2023-2028) 76
9.2.2 Central & South America Pharmaceutical Amino Acids Sales In Value By Region (2023-2028) 76
10 Company Profiles And Key Figures In Pharmaceutical Amino Acids Business 78
10.1 Ajinomoto (Japan) 78
10.1.1 Ajinomoto Corporation Information 78
10.1.2 Ajinomoto Introduction And Business Overview 79
10.1.3 Ajinomoto Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 80
10.1.4 Ajinomoto Pharmaceutical Amino Acids Products Offered 81
10.1.5 Ajinomoto Recent Development 91
10.2 Evonik (Germany) 92
10.2.1 Evonik Corporation Information 92
10.2.2 Evonik Introduction And Business Overview 93
10.2.3 Evonik Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 95
10.2.4 Evonik Pharmaceutical Amino Acids Products Offered 95
10.2.5 Evonik Recent Development 97
10.3 Kyowa Hakko (Japan) 98
10.3.1 Kyowa Hakko Corporation Information 98
10.3.2 Kyowa Hakko Introduction And Business Overview 99
10.3.3 Kyowa Hakko Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 100
10.3.4 Kyowa Hakko Pharmaceutical Amino Acids Products Offered 100
10.3.5 Kyowa Hakko Recent Development 105
10.4 Amino (Germany) 106
10.4.1 Amino Corporation Information 106
10.4.2 Amino Introduction And Business Overview 107
10.4.3 Amino Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 108
10.4.4 Amino Pharmaceutical Amino Acids Products Offered 108
10.4.5 Amino Recent Development 109
10.5 Meihua Holdings Group (China) 110
10.5.1 Meihua Holdings Group Corporation Information 110
10.5.2 Meihua Holdings Group Introduction And Business Overview 111
10.5.3 Meihua Holdings Group Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 112
10.5.4 Meihua Holdings Group Pharmaceutical Amino Acids Products Offered 112
10.5.5 Meihua Holdings Group Recent Development 113
10.6 Tianjin Tianyao (China) 114
10.6.1 Tianjin Tianyao Corporation Information 114
10.6.2 Tianjin Tianyao Introduction And Business Overview 114
10.6.3 Tianjin Tianyao Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 115
10.6.4 Tianjin Tianyao Pharmaceutical Amino Acids Products Offered 115
10.7 Jingjing (China) 116
10.7.1 Jingjing Corporation Information 116
10.7.2 Jingjing Introduction And Business Overview 116
10.7.3 Jingjing Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 117
10.7.4 Jingjing Pharmaceutical Amino Acids Products Offered 118
10.8 Wuxi Jinghai (China) 118
10.8.1 Wuxi Jinghai Corporation Information 118
10.8.2 Wuxi Jinghai Introduction And Business Overview 119
10.8.3 Wuxi Jinghai Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 119
10.8.4 Wuxi Jinghai Pharmaceutical Amino Acids Products Offered 120
10.9 Jiahe Biotech (China) 121
10.9.1 Jiahe Biotech Corporation Information 121
10.9.2 Jiahe Biotech Introduction And Business Overview 121
10.9.3 Jiahe Biotech Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 122
10.9.4 Jiahe Biotech Pharmaceutical Amino Acids Products Offered 122
10.10 Hubei Bafeng (China) 125
10.10.1 Hubei Bafeng Corporation Information 125
10.10.2 Hubei Bafeng Introduction And Business Overview 126
10.10.3 Hubei Bafeng Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 126
10.10.4 Hubei Bafeng Pharmaceutical Amino Acids Products Offered 127
10.10.5 Hubei Bafeng Recent Development 127
10.11 Grand Hoyo (China) 128
10.11.1 Grand Hoyo Corporation Information 128
10.11.2 Grand Hoyo Introduction And Business Overview 129
10.11.3 Grand Hoyo Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 129
10.11.4 Grand Hoyo Pharmaceutical Amino Acids Products Offered 130
10.11.5 Grand Hoyo Recent Development 133
10.12 Yichang Sanxia Proudin (China) 133
10.12.1 Yichang Sanxia Proudin Corporation Information 133
10.12.2 Yichang Sanxia Proudin Introduction And Business Overview 134
10.12.3 Yichang Sanxia Proudin Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 135
10.12.4 Yichang Sanxia Proudin Pharmaceutical Amino Acids Products Offered 135
10.12.5 Yichang Sanxia Proudin Recent Development 137
10.13 Shine Star (China) 138
10.13.1 Shine Star Corporation Information 138
10.13.2 Shine Star Introduction And Business Overview 139
10.13.3 Shine Star Pharmaceutical Amino Acids Sales, Revenue And Gross Margin (2017-2022) 140
10.13.4 Shine Star Pharmaceutical Amino Acids Products Offered 141
11 Upstream, Opportunities, Challenges, Risks And Influences Factors Analysis 142
11.1 Pharmaceutical Amino Acids Key Raw Materials 142
11.1.1 Key Raw Materials 142
11.1.2 Key Raw Materials Price 144
11.1.3 Raw Materials Key Suppliers 144
11.2 Manufacturing Cost Structure 145
11.3 Pharmaceutical Amino Acids Industrial Chain Analysis 145
11.4 Pharmaceutical Amino Acids Market Dynamics 146
11.4.1 Industry Trends 146
11.4.2 Market Drivers 146
11.4.3 Market Challenges 147
11.4.4 Market Restraints 147
12 Marketing Strategy Analysis, Distributors 149
12.1 Sales Channel 149
12.2 Pharmaceutical Amino Acids Distributors 150
12.3 Pharmaceutical Amino Acids Downstream Customers 151
13 Research Findings And Conclusion 152
14 Appendix 154
14.1 Methodology/Research Approach 154
14.1.1 Research Programs/Design 154
14.1.2 Market Size Estimation 154
14.1.3 Market Breakdown And Data Triangulation 156
14.2 Data Source 156
14.2.1 Secondary Sources 156
14.2.2 Primary Sources 157
14.3 Disclaimer 158
14.4 Author List 158

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る